PROTAGONIST THERAPEUTICS Trademark
Trademark Overview
On Monday, December 18, 2023, a trademark application was filed for PROTAGONIST THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PROTAGONIST THERAPEUTICS trademark a serial number of 98319352. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, April 15, 2025. This trademark is owned by Protagonist Therapeutics, Inc.. The PROTAGONIST THERAPEUTICS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
Providing online healthcare and medical information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders
General Information
| Serial Number | 98319352 |
| Word Mark | PROTAGONIST THERAPEUTICS |
| Filing Date | Monday, December 18, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, April 15, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 27, 2024 |
Trademark Statements
| Description of Mark | The mark consists of the word "Protagonist" above the word "Therapeutics" to the right of the words is a DNA double helix. |
| Goods and Services | Pharmaceutical preparations for the treatment of oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Providing online healthcare and medical information to patients and healthcare providers relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Scientific and medical research relating to oncological, hematological, inflammatory and autoimmune disorders, rare and orphan disorders, endocrine disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 18, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 18, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 18, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Protagonist Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
| Party Name | Protagonist Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newark, CA 94560 |
Trademark Events
| Event Date | Event Description |
| Monday, December 18, 2023 | NEW APPLICATION ENTERED |
| Tuesday, March 26, 2024 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, March 26, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 17, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 16, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, July 17, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 17, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, July 17, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, July 18, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 27, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 22, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 15, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 15, 2025 | SOU EXTENSION 1 FILED |
| Tuesday, April 15, 2025 | SOU EXTENSION 1 GRANTED |
| Wednesday, April 16, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 27, 2024 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
